Pulmonary Airway Articles & Analysis
4 news found
(“Stemedica”), a San Diego-based biotech company specializing in the manufacture of clinical grade stem cells, announced today that it has signed a Licensing Agreement with Pulthera, LLC for the rights to use, distribute and sell its mesenchymal stem cell technologies in the treatment of COVID-19 and additional pulmonary conditions. The agreement was confirmed today ...
The following are a few ways the StartX Med COVID-19 Task Force is working to provide hope, flatten the curve, and combat the novel coronavirus: Rapid tests suitable for drive through testing, nursing homes, and ER rooms with results in 10 minutes Applications and hardware to assess respiratory issues Rapid solutions to fight developing sepsis and correlating antibiotic resistance resulting ...
Paul McCray, from the University of Iowa Carver College of Medicine, demonstrate that Feldan’s engineered amphiphilic peptides (Feldan Shuttles) allow safe and efficient intracellular delivery of proteins to airway epithelia. The authors declare: "The delivery of biologic cargoes to airway epithelial cells is challenging due to the formidable barriers ...
Results from a clinical trial conducted at leading US hospitals, demonstrated that the ENvue system is safe and effective, with no tube insertions into the pulmonary airways and no occurrence of guidance-related adverse events. ...